AA
MRNA icon

Ancora Advisors’s Moderna MRNA Stock Holding History

Ancora Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.05K Sell
115
-382
-77% -$19.8K ﹤0.01% 1530
2026
Q1 		$25.2K Hold
497
– – ﹤0.01% 1437
2025
Q4 		$14.7K Buy
497
+355
+250% +$9.64K ﹤0.01% 1673
2025
Q3 		$3.67K Buy
142
+27
+23% +$753 ﹤0.01% 1561
2025
Q2 		$3.17K Sell
115
-34
-23% -$895 ﹤0.01% 1565
2025
Q1 		$4.22K Sell
149
-4
-3% -$142 ﹤0.01% 1450
2024
Q4 		$6.36K Buy
153
+2
+1% +$96 ﹤0.01% 1415
2024
Q3 		$10.1K Sell
151
-88
-37% -$8.08K ﹤0.01% 1331
2024
Q2 		$28.4K Buy
239
+3
+1% +$380 ﹤0.01% 1089
2024
Q1 		$25.1K Hold
236
– – ﹤0.01% 1142
2023
Q4 		$23.5K Sell
236
-70
-23% -$5.89K ﹤0.01% 1135
2023
Q3 		$31.6K Hold
306
– – ﹤0.01% 1036
2023
Q2 		$37.2K Sell
306
-23
-7% -$3.07K ﹤0.01% 976
2023
Q1 		$50.5K Buy
329
+96
+41% +$15.8K ﹤0.01% 910
2022
Q4 		$42K Hold
233
– – ﹤0.01% 1003
2022
Q3 		$28K Buy
233
+14
+6% +$2.12K ﹤0.01% 1254
2022
Q2 		$31K Sell
219
-1
-0.5% -$143 ﹤0.01% 1319
2022
Q1 		$38K Hold
220
– – ﹤0.01% 1358
2021
Q4 		$56K Buy
220
+4
+2% +$1.17K ﹤0.01% 1215
2021
Q3 		$83K Sell
216
-550
-72% -$203K ﹤0.01% 1031
2021
Q2 		$180K Buy
766
+100
+15% +$17.9K ﹤0.01% 771
2021
Q1 		$87K Buy
666
+1
+0.2% +$145 ﹤0.01% 920
2020
Q4 		$69K Hold
665
– – ﹤0.01% 818
2020
Q3 		$47K Buy
665
+115
+21% +$8.02K ﹤0.01% 870
2020
Q2 		$35K Hold
550
– – ﹤0.01% 892
2020
Q1 		$16K Buy
+550
New +$12.7K ﹤0.01% 1095

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Ancora Advisors's MRNA Position: Q2 2026 in Review

Ancora Advisors reduced its Moderna (MRNA) stake by 77% in Q2 2026, selling an estimated $19.8K and leaving 115 shares worth $8.05K. The position accounts for ﹤0.01% of the portfolio, ranked #1530.

Ancora Advisors first reported a position in MRNA in Q1 2020 and has held it in 26 quarters since. The position peaked at $180K in Q2 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Ancora Advisors held 115 shares of Moderna worth $8.05K as of Q2 2026.
  • Ancora Advisors sold 382 Moderna shares in Q2 2026, an estimated $19.8K.
  • Moderna made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #1530 holding.
  • Ancora Advisors first reported a position in Moderna in Q1 2020 and has held it in 26 quarters since.
  • Ancora Advisors's Moderna position peaked at $180K in Q2 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.